NVCT
Price
$8.32
Change
-$0.73 (-8.07%)
Updated
Apr 4, 02:38 PM (EDT)
Capitalization
211.69M
39 days until earnings call
UTHR
Price
$293.30
Change
-$14.06 (-4.57%)
Updated
Apr 4, 02:56 PM (EDT)
Capitalization
13.8B
26 days until earnings call
Ad is loading...

NVCT vs UTHR

Header iconNVCT vs UTHR Comparison
Open Charts NVCT vs UTHRBanner chart's image
Nuvectis Pharma
Price$8.32
Change-$0.73 (-8.07%)
Volume$1.4K
Capitalization211.69M
United Therapeutics
Price$293.30
Change-$14.06 (-4.57%)
Volume$200
Capitalization13.8B
NVCT vs UTHR Comparison Chart
Loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVCT vs. UTHR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVCT is a Hold and UTHR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (NVCT: $9.05 vs. UTHR: $307.36)
Brand notoriety: NVCT and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVCT: 74% vs. UTHR: 84%
Market capitalization -- NVCT: $211.69M vs. UTHR: $13.8B
NVCT [@Biotechnology] is valued at $211.69M. UTHR’s [@Biotechnology] market capitalization is $13.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVCT’s FA Score shows that 0 FA rating(s) are green whileUTHR’s FA Score has 1 green FA rating(s).

  • NVCT’s FA Score: 0 green, 5 red.
  • UTHR’s FA Score: 1 green, 4 red.
According to our system of comparison, UTHR is a better buy in the long-term than NVCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVCT’s TA Score shows that 4 TA indicator(s) are bullish while UTHR’s TA Score has 4 bullish TA indicator(s).

  • NVCT’s TA Score: 4 bullish, 6 bearish.
  • UTHR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than NVCT.

Price Growth

NVCT (@Biotechnology) experienced а -6.22% price change this week, while UTHR (@Biotechnology) price change was -0.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.31%. For the same industry, the average monthly price growth was -17.16%, and the average quarterly price growth was -18.95%.

Reported Earning Dates

NVCT is expected to report earnings on May 13, 2025.

UTHR is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (-11.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.8B) has a higher market cap than NVCT($212M). NVCT YTD gains are higher at: 67.283 vs. UTHR (-12.890). UTHR has higher annual earnings (EBITDA): 1.65B vs. NVCT (-19.85M). UTHR has more cash in the bank: 3.27B vs. NVCT (18.5M). UTHR has higher revenues than NVCT: UTHR (2.88B) vs NVCT (0).
NVCTUTHRNVCT / UTHR
Capitalization212M13.8B2%
EBITDA-19.85M1.65B-1%
Gain YTD67.283-12.890-522%
P/E RatioN/A12.47-
Revenue02.88B-
Total Cash18.5M3.27B1%
Total DebtN/A300M-
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
14
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
40
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVCTUTHR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 19 days ago
71%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 8 days ago
58%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMLPX10.98N/A
N/A
Westwood Salient MLP & Engy Infras Inst
SVFFX77.31N/A
N/A
Smead Value I1
HFEDX49.25N/A
N/A
Janus Henderson European Focus D
MAIJX17.28N/A
N/A
Morgan Stanley Inst Passport ovrs eq R6
MSDQX11.97N/A
N/A
Morgan Stanley Emerging Mkt ex China A

NVCT and

Correlation & Price change

A.I.dvisor tells us that NVCT and DARE have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NVCT and DARE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCT
1D Price
Change %
NVCT100%
-4.33%
DARE - NVCT
30%
Poorly correlated
+0.69%
FTRE - NVCT
28%
Poorly correlated
-9.59%
RCKT - NVCT
26%
Poorly correlated
-11.75%
UTHR - NVCT
26%
Poorly correlated
-1.57%
CELU - NVCT
26%
Poorly correlated
-6.13%
More

UTHR and

Correlation & Price change

A.I.dvisor tells us that UTHR and GERN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UTHR and GERN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-1.57%
GERN - UTHR
32%
Poorly correlated
-7.55%
DAWN - UTHR
31%
Poorly correlated
-3.26%
MNKD - UTHR
30%
Poorly correlated
-2.79%
HALO - UTHR
30%
Poorly correlated
-1.75%
TECH - UTHR
30%
Poorly correlated
-6.03%
More